✌️STOCK TRADERS ✌️
Open in Telegram
Disclaimer!!!!!! Im not SEBI Registered All trades And recommendations are Only for Educational purpose I'll not be Responsible for your profit/Loss. Contact Admin @Abhishekstocks Whatsapp https://wa.me/916263155349
Show more1 112
Subscribers
No data24 hours
-37 days
-1430 days
Posts Archive
1 112
⚜️BUY RELIANCE 2800 CE ABOVE- 85
🎯 Target -90-100-120
❤Sl - PAID
Wait for hit
1 112
तैयार हो जाओ दोस्तों आज
SENSEX Expiry है और
आज बम्पर
profit लेंगे एक दिन में capital double
और फ़ीस भी recover करके profit बनायेंगे 😍
💥Only Paid client
💥Finnifty Jackpots
💥 ONLY Limited SEAT AVAILABLE
🔴Premium group
JOIN IN BIG DISCOUNTS
https://wa.me/916263155349
1 112
Repost from ✌️STOCK TRADERS ✌️
Open a Angel One demat account using my link and join premium group free of cost with lifetime validity
Account opening link 👇
https://angel-one.onelink.me/Wjgr/i4qrcwrl
❤️ Now account opening in Angel One 100% FREE
After opened angel account message
ALREADY ANGEL ONE USER TRANSFER GET FREE PAID SERVICE
👉👉message https://wa.me/916263155349
1 112
My paid service BENIFIT
BEST SUGGESTIONS IPO
stock option
Equity holding trade
Banknifty trade
Index trade
Hero zero trade
Future trade
Proper entry to exit level
https://wa.me/916263155349
1 112
Repost from ✌️STOCK TRADERS ✌️
Open a Angel One demat account using my link and join premium group free of cost with lifetime validity
Account opening link 👇
https://angel-one.onelink.me/Wjgr/i4qrcwrl
❤️ Now account opening in Angel One 100% FREE
After opened angel account message
ALREADY ANGEL ONE USER TRANSFER GET FREE PAID SERVICE
👉👉message https://wa.me/916263155349
1 112
Mankind Pharma
The company has received regulatory approvals, including approval from the Competition Commission of India, for the acquisition of Bharat Serums and Vaccines. In July 2024, the Share Purchase Agreement was executed between the company, Bharat Serums and Vaccines, the sellers (Ansamira and Miransa—affiliates of funds managed by Advent International), and certain minority shareholders (Bhaskar Iyer and Abhijit Mukherjee) for the acquisition of a 100% stake in Bharat Serums and Vaccines.
Zydus Lifesciences
The pharmaceutical company has received tentative approval from the USFDA to manufacture Enzalutamide tablets in 40 mg and 80 mg strengths. Enzalutamide is used for treating castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer.
Ashoka Buildcon
The infrastructure company has received a letter of award for a project worth Rs 474.10 crore from MMRDA, involving the design and construction of an elevated road from Kalyan Murbad Road to Badlapur Road to Pune Link Road. Additionally, it has bagged two more letters of award for contracts worth Rs 1,264 crore, which include the design and construction of a creek bridge from Kolshet to Kalher, and another from Gaimukh to Payegaon.
Eicher Motors
Royal Enfield sales increased by 11% year-on-year to 86,978 units, exceeding analysts' estimates, compared to 78,580 units sold in September last year. Exports in September jumped by 77% to 7,652 units, compared to 4,319 units in the same month last year.
Hero MotoCorp
The two-wheeler major has announced sales of 6.37 lakh units in September 2024, beating analysts' estimates and growing by 18.7% over the 5.36 lakh units sold in the same month last year. Domestic sales increased by 18.6% year-on-year to 6.16 lakh units, and exports grew by 21.7% to 20,344 units during the month.
Maruti Suzuki India
The country's largest carmaker recorded total sales of 1.84 lakh units in September 2024, marking a 1.9% increase from the 1.81 lakh units sold in the same month last year. Total domestic sales fell by 1.15% to 1.57 lakh units, as domestic passenger vehicle sales dropped by 3.9% to 1.45 lakh units. However, total exports jumped by 23.2% to 27,728 units compared to September 2023.
Dabur India
While demand trends showed some improvement, heavy rain and floods across parts of the country impacted out-of-home consumption and consumer offtake during Q2FY25. This led to some negative impact on its business, especially in the beverage category. The company is expected to post a mid-single-digit decline in consolidated revenue for the quarter, although its international business is expected to register double-digit constant currency growth in topline. The Badshah Masala business continued to perform well, growing in double digits in Q2. However, low primary sales will impact the company’s profitability in Q2, and the operating margin is expected to decline in the mid-to-high teens due to deleveraging and continued investments in brands.
South Indian Bank
The lender recorded gross advances at Rs 84,741 crore (provisional numbers) for Q2FY25, growing by 13.07% from Rs 74,947 crore in the same quarter last year. Total deposits during the same period increased by 8.6% to Rs 1.05 lakh crore, while CASA grew by 8% year-on-year to Rs 33,583 crore in Q2FY25.
ITC
ITC Infotech India, a subsidiary of the company, has acquired 100% shares of Blazeclan Technologies for Rs 485 crore. Consequently, Blazeclan and its subsidiaries have become step-down wholly owned subsidiaries of the company, effective October 1.
Available now! Telegram Research 2025 — the year's key insights 
